Immuneering

IMRX

IMRX Immuneering NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    IMRX Chart
    See on advanced chart >

    About

    Immuneering Corporation was incorporated in Delaware in 2008. The company uses bioinformatics to develop new drugs that are not possible with traditional drug discovery methods. The company's current pipeline of drug candidates focuses on the treatment of...
    • Highlight
      A biopharmaceutical company that advance several products for cancer and other diseases
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      07/30/2021
    • Established Date
      Invalid Date
    • Full-time Employees
      68
    • Address
      245 Main Street Second Floor Cambridge MA 02142
    • Tel
      1-617-5008080
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock